Lilly completes biopharma acquisitions
Lilly expands its portfolio of treatments for cardiometabolic diseases with…
Lilly expands its portfolio of treatments for cardiometabolic diseases with acquisition of Versanis Bio and Sigilon Therapeutics.
List view / Grid view
Lilly expands its portfolio of treatments for cardiometabolic diseases with…
Lilly expands its portfolio of treatments for cardiometabolic diseases with acquisition of Versanis Bio and Sigilon Therapeutics.
Eli Lilly and Company has announced the acquisition of California-based…
Eli Lilly and Company has announced the acquisition of California-based biotech company, Protomer Technologies.